Asking for help or giving instructions can feel intimidating, but being pushy helps ensure patients' well-being, says ...
A brain implant helps paralyzed patients type on a computer by decoding attempted finger movements. The device enables rapid, ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
Amydis has received $2.5 million to continue mapping toxic deposits of TDP-43 in retinal tissue and develop an eye test for ...
Keros Therapeutics will use the Massachusetts General Hospital MyMatch program to design a clinical trial testing ...
Columnist Juliet Taylor reflects on the legacy of Leah Stavenhagen, who founded Her ALS Story for young women diagnosed with the disease.
Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
Hearing how a family found meaning in the midst of their loss reminds columnist Kristin Neva that she isn't alone in her ...
For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results